180 Life Sciences Corp. (ATNF) stock rallied over 2.48% intraday to trade at $0.85 a share on NASDAQ. The stock opened with a gain of 1.80% at $0.86 and touched an intraday high of $0.888, rising 2.66% against the last close of $0.828. The stock went to a low of $0.8 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
180 Life Sciences Corp. (NASDAQ: ATNF) stock price is $0.85 as of the last check on Thursday, June 30. During the trading session, ATNF stock reached the peak price of $0.888 while $0.8 was the lowest point it dropped to.
The NASDAQ listed ATNF is part of Biotechnology industry that operates in the broader Health Care sector. 1180 Life Sciences Corp. , a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases.
Prof. Raphael Mechoulam Ph.D.
Dr. James N. Woody M.D., Ph.D.
CEO & Director
Mr. Ozan Pamir C.F.A.
Interim CFO & Sec.
Dr. Jonathan B. Rothbard Ph.D.
Chief Scientific Officer
ATNF stock traded closed the last session at $0.848, which is $0.02 or 2.48% lower than its previous close of $0.828. ATNF's current trading price is 7.35% lower than its 52-week high of $11.20 where as its distance from 52-week low of 0.79% is -92.43%.
Number of ATNF employees currently stands at -. ATNF operates from Building 4, 3000 El Camino Real Suite 200, Palo Alto, CA 94306, United States.
Official Webiste of $ATNF is: https://180lifesciences.com
ATNF stock volume for the day was 126,855 shares while in the previous session number of ATNF shares traded was 126,855 . The average number of ATNF shares traded daily for last 3 months was 487.23 Thousands.
The percentage change in ATNF stock occurred in the recent session was 2.48% while the dollar amount for the price change in ATNF stock was $0.02.
In the recent session, the day high for ATNF stock was $0.888 while the low for ATNF stock touched on the day was $0.8.
The market value of ATNF currently stands at 27.53 Million with its latest stock price at $0.85 and 32.46 Million of its shares outstanding.